Loading...
Explore Molbio Diagnostics IPO details, including IPO dates, financial statements, valuation, peer comparison and more.
Company Overview: Molbio Diagnostics Limited
Incorporated in 2000, Molbio Diagnostics Limited is a point-of-care (POC) diagnostics company focused on providing accurate, rapid, and cost-effective healthcare solutions for infectious and non-communicable diseases. The company serves public health programs, diagnostic laboratories, and hospitals through a business model driven by device sales and recurring revenue from proprietary test kits. Beyond molecular diagnostics, the company offers radiology, digital pathology, and breast health screening solutions through its subsidiaries and partners.
Key Highlights
Discover essential information crucial for understanding an IPO, including the Price Band, Fresh Issue, Offer For Sale, Total IPO Size and more. Explore these key details to gain insight into the company's public offering.
| Fields | Details |
|---|---|
| IPO Dates | 10 Aug - 12 Aug 2026 |
| IPO Price Band | ₹768 - ₹807 per share |
| Fresh Issue | ₹200.00 crore |
| Offer For Sale | ₹739.70 crore |
| Total IPO Size | ₹939.70 crore |
| Face Value | ₹1 |
| Listing On | BSE, NSE |
Explore important dates like IPO opening, closing, listing and others, outlining the journey of the Public Offering. This will help you grasp the entire IPO journey effortlessly.
| Event | Date |
|---|---|
| IPO Opening Date | 10 Aug 2026 |
| IPO Closing Date | 12 Aug 2026 |
| Basis Of Allotment | 13 Aug 2026 |
| Refunds | 14 Aug 2026 |
| Demat Transfer | 14 Aug 2026 |
| IPO Listing Date | 17 Aug 2026 |
Explore a comprehensive financial data table showcasing key metrics including revenue, expenses, net income, and others. Gain valuable insights about the company's financial performance at a glance, facilitating informed decision-making and strategic planning for subscribing to the IPO.
| Period Ended | 31 Mar 2024 | 31 Mar 2025 | 31 Mar 2026 |
|---|---|---|---|
| Assets | 1,221.06 | 1,461.56 | 2,148.42 |
| Total Income | 840.66 | 1,027.94 | 1,455.17 |
| Profit After Tax | 83.54 | 138.58 | 164.14 |
| EBITDA | 185.09 | 256.64 | 328.24 |
| NET Worth | 807.94 | 952.95 | 1,144.68 |
| Reserves and Surplus | 845.48 | 990.84 | 1,148.84 |
| Total Borrowing | 174.58 | 123.16 | 412.64 |
* NPM represents the net profit margin, calculated as a percentage. All other figures are presented in crore (₹cr)
Compare key financial metrics with industry peers to gain valuable insights into the company's performance compared to its competitors.
| Name | P/E | EPS | RoNW | NAV |
|---|---|---|---|---|
| Molbio Diagnostics Ltd. | 54.64 | 14.77 | 14.55% | 101.51 |
| Vijaya Diagnostic Centre Ltd | 81.02 | 16.79 | 18.07% | 93.02 |
| Metropolis Healthcare Ltd | 63.72 | 9.19 | 12.56% | 72.98 |
| Dr. Lal Pathlabs Ltd | 62.2 | 30.2 | 20.78% | 145 |
| Poly Medicure Ltd | 52.61 | 31.75 | 10.37% | 306.45 |
* Revenue in (₹cr), RoNW in (%), EPS, NAV in (₹). P/E ratio is based on the highest price from the IPO price band.
| Investor Type | Shares Offered |
|---|---|
| Retail Individual Investor (RII) | Not less than 35% of the Net Offer |
| Investor Type | Subscribed |
|---|---|
| Qualified Institutional Buyer (QIB) | 1.39 |
| Non-Institutional Investor (NII/HNI) | 4.46 |
| Retail Individual Investor (RII) | 3.19 |
| Total | 2.95 |
* All figures represent multiples of the subscription. Check subscriptions for other ongoing issues here.
KFin Technologies Limited
Phone: +91 40 6716 2222/ 18003094001
Email: einward.ris@kfintech.com
Website: www.kfintech.com
Molbio Diagnostics Ltd.Plot No. L-46
Phase II-D, Verna Industrial Area
Verna, Salcete
South Goa, Goa – 403722
Website: https://www.molbiodiagnostics.com/
Phone: 8326724888